Sign in

CIK 0001339970

  • Non-accelerated filer
  • Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203435077
Phone
+1 858-731-8389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4/A Derivatives Options or other derivatives
  3. 4/A Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Financial Officer sold 390 shares at $7.66 ($2,987)
  5. 4 Open-market sale President and CEO sold 778 shares at $7.66 ($5,959)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Director sold 7,360 shares at an average $4.01 ($29,513)
  10. 4 Open-market sale Director sold 7,640 shares at an average $4.15 ($31,701)
  11. 4 Open-market buy Chief Financial Officer bought 1,850 shares at $4.22 ($7,807)
  12. 4 Open-market buy President and CEO bought 6,000 shares at $4.27 ($25,620)
  13. 4 Open-market sale General Counsel sold 322 shares at $3.62 ($1,166)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Director sold 8,447 shares at $3.64 ($30,739)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 17 · 329 filings